Financing and Reimbursement in Biomedical Product Development

RGA 6250 4 Quarter Hours
Course Level CPS - Graduate
Description Introduces the complex discipline of market access and pricing strategy for medical device, drug, and biologic products. As cost and relative efficacy drivers become increasingly important to market biomedical products successfully, life-sciences regulatory professionals must evaluate regulatory compliance criteria in relation to reimbursement and product pricing concerns. Regulatory professionals must also be involved in demonstrating that utilization of new biomedical products is comparatively cost-effective when measured against standards of clinical care. Using specific case studies from the United States and abroad, offers students an opportunity to analyze these market developments, as well as their resulting implications for biomedical product development, manufacturing, and commercialization, with an overall objective to develop comparatively and financially informed regulatory systems.

Prerequisites

Students should refer to the CPS Prerequisite Table for course prerequisite and corequisite information.

 

Course Sections

There are no current sections scheduled for this course. Undergraduate course numbers changed beginning with the Fall 2016 term. Please make sure you are using the current course number.
Next Term Starts

Academic Calendar

Talk to an Enrollment Coach

We can walk you through your program options and the application process.

 

Call Toll Free:
877.668.7727
Email:
Contact Us
©